US Patent Issued to Syracuse University, Xeragenx on Oct. 3 for "Glycemic control using intrinsic factor bound to a vitamin B 12 conjugate of a glucagon-like peptide-1 receptor agonist" (New York, Missouri Inventors)

Media coverage

• Title	US Patent Issued to Syracuse University, Xeragenx on Oct. 3 for "Glycemic control using intrinsic factor bound to a vitamin B 12 conjugate of a glucagon-like peptide-1 receptor agonist" (New York, Missouri Inventors)
  Media name/outlet	US Fed News
  Country/Territory	United States
  Date	10/4/23
  Persons	Robert Patrick Doyle